Theracryf (LON:TCF – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported GBX (6) earnings per share for the quarter, Digital Look Earnings reports. Theracryf had a negative net margin of 792.17% and a negative return on equity of 99.97%.
Theracryf Price Performance
TCF stock opened at GBX 0.21 on Wednesday. The company has a market cap of £4.51 million, a price-to-earnings ratio of -0.58 and a beta of 1.42. The company has a fifty day moving average price of GBX 0.21 and a 200 day moving average price of GBX 0.23. Theracryf has a 12 month low of GBX 0.18 and a 12 month high of GBX 1.25.
About Theracryf
Behavioural brain disorders such as opioid and alcohol abuse, binge eating disorder, anxiety and fatigue affect more than 50 million people worldwide.
Featured Articles
- Five stocks we like better than Theracryf
- Election Stocks: How Elections Affect the Stock Market
- The $100 Million Tell: Following Smart Money Into DoorDash
- Why Invest in High-Yield Dividend Stocks?
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- What Makes a Stock a Good Dividend Stock?
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
Receive News & Ratings for Theracryf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theracryf and related companies with MarketBeat.com's FREE daily email newsletter.
